Literature DB >> 26548541

Standards and guidelines for observational studies: quality is in the eye of the beholder.

Sally C Morton1, Monica R Costlow2, Jennifer S Graff3, Robert W Dubois3.   

Abstract

OBJECTIVES: Patient care decisions demand high-quality research. To assist those decisions, numerous observational studies are being performed. Are the standards and guidelines to assess observational studies consistent and actionable? What policy considerations should be considered to ensure decision makers can determine if an observational study is of high-quality and valid to inform treatment decisions? STUDY DESIGN AND
SETTING: Based on a literature review and input from six experts, we compared and contrasted nine standards/guidelines using 23 methodological elements involved in observational studies (e.g., study protocol, data analysis, and so forth).
RESULTS: Fourteen elements (61%) were addressed by at least seven standards/guidelines; 12 of these elements disagreed in the approach. Nine elements (39%) were addressed by six or fewer standards/guidelines. Ten elements (43%) were not actionable in at least one standard/guideline that addressed the element.
CONCLUSION: The lack of observational study standard/guideline agreement may contribute to variation in study conduct; disparities in what is considered credible research; and ultimately, what evidence is adopted. A common set of agreed on standards/guidelines for conducting observational studies will benefit funders, researchers, journal editors, and decision makers.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Comparative effectiveness research; Observational studies; Standards

Mesh:

Year:  2015        PMID: 26548541     DOI: 10.1016/j.jclinepi.2015.10.014

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  9 in total

1.  Housing Stability and Medication Adherence among HIV-Positive Individuals in Antiretroviral Therapy: A Meta-Analysis of Observational Studies in the United States.

Authors:  Rebecca Arden Harris; Xiaonan Xue; Peter A Selwyn
Journal:  J Acquir Immune Defic Syndr       Date:  2017-03-01       Impact factor: 3.731

2.  Evidence-Based Neonatal Unit Practices and Determinants of Postnatal Corticosteroid-Use in Preterm Births below 30 Weeks GA in Europe. A Population-Based Cohort Study.

Authors:  Alexandra Nuytten; Hélène Behal; Alain Duhamel; Pierre-Henri Jarreau; Jan Mazela; David Milligan; Ludwig Gortner; Aurélie Piedvache; Jennifer Zeitlin; Patrick Truffert
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

3.  Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?

Authors:  Sajan Khosla; Robert White; Jesús Medina; Mario Ouwens; Cathy Emmas; Tim Koder; Gary Male; Sandra Leonard
Journal:  F1000Res       Date:  2018-01-25

4.  The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME).

Authors:  David Pérol; Mathieu Robain; Patrick Arveux; Simone Mathoulin-Pélissier; Emmanuel Chamorey; Bernard Asselain; Delphine Berchery; Sophie Gourgou; Mathias Breton; Stéphanie Delaine-Clisant; Muriel Mons; Véronique Diéras; Matthieu Carton; Anne-Valérie Guizard; Lilian Laborde; Carine Laurent; Agnès Loeb; Marie-Ange Mouret-Reynier; Damien Parent; Geneviève Perrocheau; Loïc Campion; Michel Velten; Christian Cailliot; Monia Ezzalfani; Gaëtane Simon
Journal:  BMJ Open       Date:  2019-02-21       Impact factor: 2.692

5.  Aneurysmal Subarachnoid Hemorrhage Associated with Small Aneurysms in Smokers and Women: A Retrospective Analysis.

Authors:  Luisa F Figueredo; María Camila Pedraza-Ciro; Juan Sebastian Lopez-McCormick; Roberto Javier Rueda-Esteban; Juan Armando Mejía-Cordovez
Journal:  World Neurosurg X       Date:  2019-05-21

6.  Considerations in characterizing real-world data relevance and quality for regulatory purposes: A commentary.

Authors:  Cynthia J Girman; Mary E Ritchey; Wei Zhou; Nancy A Dreyer
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-12-05       Impact factor: 2.890

7.  How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment tools.

Authors:  Elvira D'Andrea; Lydia Vinals; Elisabetta Patorno; Jessica M Franklin; Dimitri Bennett; Joan A Largent; Daniela C Moga; Hongbo Yuan; Xuerong Wen; Andrew R Zullo; Thomas P A Debray; Grammati Sarri
Journal:  BMJ Open       Date:  2021-03-24       Impact factor: 2.692

8.  A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings.

Authors:  Yot Teerawattananon; Thunyarat Anothaisintawee; Chatkamol Pheerapanyawaranun; Siobhan Botwright; Katika Akksilp; Natchalaikorn Sirichumroonwit; Nuttakarn Budtarad; Wanrudee Isaranuwatchai
Journal:  PLoS One       Date:  2022-01-11       Impact factor: 3.240

9.  Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making.

Authors:  Grammati Sarri; Elisabetta Patorno; Hongbo Yuan; Jianfei Jeff Guo; Dimitri Bennett; Xuerong Wen; Andrew R Zullo; Joan Largent; Mary Panaccio; Mugdha Gokhale; Daniela Claudia Moga; M Sanni Ali; Thomas P A Debray
Journal:  BMJ Evid Based Med       Date:  2020-12-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.